Verdad Biotech Fund, L.P. is a hedge fund based in Boston, Massachusetts. According to its most recent Form D, filed Jun 9, 2026, the fund has sold $8,099,001 of interests to 9 investors since its first sale in Apr 2026. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Based on its first sale date and the amount raised, AltMountain classifies it as an emerging manager. Related persons named in the filing include Verdad Asset Management; Dan Rasmussen; VCLF GP, L.p.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to AltMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $8,099,001Cumulative sales reported on Form D
- Investors
- 9
- First sale
- Apr 1, 2026
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Verdad Asset Management; Dan Rasmussen; VCLF GP, L.p
- Latest Form D
- Jun 9, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Verdad Biotech Fund, L.P.
What is the minimum investment for Verdad Biotech Fund, L.P.?
Verdad Biotech Fund, L.P.'s latest Form D, filed Jun 9, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Verdad Biotech Fund, L.P.?
Verdad Biotech Fund, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Verdad Biotech Fund, L.P. raised?
Verdad Biotech Fund, L.P. reports $8,099,001 sold from 9 investors on its Form D filed Jun 9, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is Verdad Biotech Fund, L.P. based?
Verdad Biotech Fund, L.P. is based in Boston, Massachusetts and is managed by Verdad Advisers, L.P..
When did Verdad Biotech Fund, L.P. launch?
Verdad Biotech Fund, L.P. reports its first sale in Apr 2026, which makes it an emerging manager by AltMountain's definition (first sale in 2021 or later and under $50 million raised).
Size compared with every hedge fund
Raised more than 15% of the 474 hedge funds based in Massachusetts, and more than 19% of all 10,308 that report sales.